M&A Deal Summary |
|
---|---|
Date | 2022-05-13 |
Target | GVB Biopharma |
Sector | Life Science |
Buyer(s) | 22nd Century Group |
Deal Type | Add-on Acquisition |
Advisor(s) | Cowen Group, Inc. (Financial) Dorsey & Whitney (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1998 |
Sector | Life Science |
Employees | 64 |
Revenue | 32M USD (2023) |
22nd Century Group is a plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century Group is based in Buffalo, New York.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 3 |
State (Nevada) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2022) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-01-24 |
RX Pharmatech
Bradford, United Kingdom RX Pharmatech is a distributor of cannabinoids with 1,276 novel food applications with the U.K. Food Standards Agency (FSA). RX Pharmatech is based in Bradford, United Kingdom. |
Buy | - |